P Cafforio
Overview
Explore the profile of P Cafforio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
198
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Silvestris E, Cafforio P, DOronzo S
Hum Reprod
. 2018 Feb;
33(5):979.
PMID: 29474551
No abstract available.
2.
Notarnicola A, Vicenti G, Maccagnano G, Silvestris F, Cafforio P, Moretti B
J Biol Regul Homeost Agents
. 2016 Dec;
30(4 Suppl 1):139-144.
PMID: 28002911
The effects of treatment with shock waves (SW) on osteoblastic cells have already been described. Furthermore, the effects of treatment with SW are also determined by the contextual stimulation of...
3.
Silvestris F, Grinello D, Tucci M, Cafforio P, Dammacco F
Lupus
. 2003 Feb;
12(1):8-14.
PMID: 12587820
Peripheral T cell apoptosis is upregulated in active SLE, in parallel with high expression of both membrane-bound and soluble (s) Fas. Previous studies postulated that sFas down-regulates apoptosis in vitro...
4.
Silvestris F, Williams R, Calvani N, Grinello D, Tucci M, Cafforio P, et al.
Clin Exp Med
. 2002 Jun;
2(1):13-27.
PMID: 12049185
Apoptosis is deregulated in active systemic lupus erythematosus and Fas is overexpressed by T cells, although the role of its soluble form (sFas) is unclear. We have explored both the...
5.
Avolio C, Ruggieri M, Cafforio P, Giuliani F, Silvestris F, Dammacco F, et al.
J Neurol Sci
. 2001 Jun;
186(1-2):65-73.
PMID: 11412874
We investigate the in vivo and in vitro effects of short-term treatment with recombinant Interferon beta-1a (rIFNbeta-1a) on CD4(+)CD45RO(+) activated/memory peripheral blood T-lymphocytes (PBTLs) expressing Leukocyte Function Antigen-1 (LFA-1; CD11a/CD18)...
6.
Silvestris F, Grinello D, Del Prete A, Cafforio P, Quarto M, Dammacco F
AIDS Res Hum Retroviruses
. 2001 May;
17(7):603-14.
PMID: 11375056
Deregulation of the Fas/FasL pathway in activated T cells is suspected to contribute to the abnormal apoptosis that drives their progressive depletion during HIV-1 infection. However, the role of serum...
7.
Silvestris F, Tucci M, Cafforio P, Dammacco F
Blood
. 2001 Feb;
97(5):1155-64.
PMID: 11222356
Highly malignant myeloma cells up-regulate their Fas-ligand (Fas-L) to escape immune surveillance by Fas(+) cytotoxic cells. Here it is demonstrated that this abnormality is involved in the pathogenesis of the...
8.
Silvestris F, Cafforio P, Tucci M, Del Prete A, Dammacco F
Mol Med
. 2000 Sep;
6(6):509-26.
PMID: 10972087
Background: Recent studies indicate that soluble Fas (sFas) may modulate T-cell apoptosis, since it inhibits Fas-ligand (Fas-L)-mediated cytotoxicity in vitro. Here, we explored whether the soluble receptor and its major...
9.
Silvestris F, Cocco T, Cafforio P, Calvani N, Dammacco F
Mol Med
. 2000 Sep;
6(6):494-508.
PMID: 10972086
Unlabelled: Previous studies have demonstrated that immunoglobulin G (IgG) antibodies to VEINCTR-N, a domain shared by Fas (CD95/Apo-I) and gp120, contribute to T-cell apoptosis during human immunodeficiency virus-type 1 (HIV-1)...
10.
Frassanito M, Dammacco R, Cafforio P, Dammacco F
Arthritis Rheum
. 1999 Oct;
42(9):1967-74.
PMID: 10513814
Objective: To investigate whether immunologic abnormalities in patients with Behçet's disease (BD) are related to abnormalities of the Th1/Th2 ratio. Methods: Th1/Th2 cytokine production by peripheral blood lymphocytes (PBL) from...